Click Here to Register
This webinar is the first in a series of summer symposia from Penn State’s Program for Translational Research on Adversity and Neurodevelopment (P-TRAN)
Despite notable advances in identifying the biological pathways that confer risk for or resilience to substance use disorders (SUDs), the effective transfer and application of this scientific knowledge from the neurosciences and related biomedical fields to SUD prevention science is sorely lacking. Advances in the integration of neuroscience and prevention (i.e., so-called “neuro-prevention”) are needed and have the potential to inform the delineation of which types of intervention work best for whom, why, and under what circumstances.
The P-TRAN summer symposium series will convene investigators whose work is or could be aligned with a translational neuroscience approach to developing more effective interventions to disrupt pathways to SUDs. This series will bring substance use investigators and trainees from biomedical/neuroscience and prevention science together with invested stakeholders, with the aim of advancing a transdisciplinary, translational approach to address the gaps in SUD prevention.
Presenters:
Diana H. Fishbein Ph.D.
Dr. Fishbein is Research Faculty in the Dept. of Human Development and Family Studies and Director of the Program for Translational Research on Adversity and Neurodevelopment in the Edna Bennett Pierce Prevention Research Center at Penn State. She is also a Senior Scientist at the Frank Porter Graham Child Development Institute at the University of North Carolina. She has deep expertise in the field of substance abuse, studying impacts of deleterious social contextual factors (e.g., adverse childhood experiences) on brain development and behavioral health in children and adolescents. Dr. Fishbein’s research aims to determine effective means of disrupting pathways to SUD in at-risk youth and identifying sources of differential responses to intervention. Given the actionable nature of this research, she founded and directs the National Prevention Science Coalition to Improve Lives (NPSC), a large professional organization dedicated to the transfer of knowledge from science to public health policies.
Susan L. Andersen Ph.D.
Dr. Andersen is an Associate Professor in the Department of Psychiatry at Harvard Medical School. She has published extensively and was funded by the NIH for over 20 years. She studies the process of brain development in preclinical animal models. The goal of her research is to identify novel treatments for ADHD or for individuals exposed to early adversity that reduce risk for substance use. Her research shows that early preventative interventions to drug-seeking and related risk behaviors are possible by manipulating relevant cortical mechanisms before adolescence.
Scott C. Bunce, Ph.D.
Scott C. Bunce, Ph.D. is a Clinical Psychologist and an Associate Professor of Psychiatry and Behavioral Health at Penn State Hershey Medical Center and Penn State College of Medicine, and an Adjunct Professor in the School of Biomedical Engineering, Science & Health Systems at Drexel University. His research interests lie at the intersection of clinical and affective neuroscience, with a focus on translational neuroimaging to elucidate the influence of emotional and motivational processes in healthy and psychopathological behavior, especially in reward processing and interpersonal relationships. Dr. Bunce’s research includes developing objective, brain-based measures of vulnerability to relapse in substance use disorders and the use of neurofeedback as an adjunct treatment in addiction. This work has been funded by several federal and private agencies (NIDA, DOD, DARPA, ONR, DHS, FAA, PA DoH CURE Funds, Coulter Foundation, and the Klarman Family Foundation).
- Flyer Translational Neuroscience Perspectives On Substance Abuse Prevention
